辉瑞 PFE 深 沪
等待开盘 01-08 09:30:00 美东时间
25.28
-0.150
-0.59%
华盛通- 最 高25.81
- 今 开25.59
- 成交量 5139.23万股
- 最 低 25.14
- 昨 收 25.43
- 总市值 1437.42亿
- 52周最高 27.26
- 市盈率 静 17.97
- 换手率 0.90%
- 52周最低 19.625
- 委 比 -90.30%
- 总股本 56.86亿
- 历史最高 55.07
- 量 比 1.30
- 振 幅 2.63%
- 历史最低 -2.6173
- 每 手 1
- 风险率 1.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
25分钟前
美股异动 | 减肥药概念走高 礼来(LLY.US)涨超4%破历史新高
周三，减肥药概念走高，礼来(LLY.US)涨超4%破历史新高，安进(AMGN.US)涨超3%，诺和诺德(NVO.US)、辉瑞(PFE.US)涨超1%。
01-07 23:00
“专利悬崖”大限将至 制药行业或迎来新一轮资产争夺战
①全球多款畅销药面临专利保护到期，预计到2032年将给制药巨头造成至少1739亿美元的年销售额损失； ②为填补收入缺口，制药公司正通过并购、合作、授权等方式获取新药或创新成果，预计2026年并购活动可能进一步升温。
01-07 21:57
UBS Assumes Pfizer at Neutral, Announces Price Target of $25
UBS analyst Michael Yee assumes Pfizer (NYSE:PFE) with a Neutral rating and announces Price Target of $25.
01-07 21:45
8.65亿！辉瑞又出手了
（来源：动脉新医药） 1月6日，辉瑞（Pfizer）宣布与美国肿瘤免疫疗法公司Cartography Biosciences达成一项研发合作，双方将围绕“肿瘤选...
01-07 18:20
拜耳就mRNA技术起诉美国新冠疫苗制造商
拜耳旗下的孟山都公司周二在特拉华州联邦法院起诉新冠疫苗生产商辉瑞、BioNTech和Moderna，指控它们在生产疫苗时滥用其mRNA技术。该专利侵权诉讼称，这...
01-07 04:41
Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development
Outlook Therapeutics, Inc. announced the appointment of Laura Cantrell as Vice President of Corporate Strategy and Business Development. Cantrell, with over 20 years of experience in biotechnology, will lead the company's business development strategies, strategic partnerships, and corporate initiatives. Her expertise will support the company's mission to enhance bevacizumab treatments for retina diseases and maximize shareholder value.
01-06 13:35
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Nurix Therapeutics, Inc. announced that its CEO, Arthur T. Sands, M.D., Ph.D., will present a corporate update at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, in San Francisco. The presentation will be available via webcast on the company's website. Nurix, focused on targeted protein degradation medicines for oncology and autoimmune diseases, has a clinical-stage pipeline including BTK degraders and CBL-B inhibitors, as ...
01-05 12:00
美股1月收息策略：最高股息率超8%！辉瑞、蒙特利尔银行等超40家高分红股如何布局！
最高股息率超8%！辉瑞、丰业银行、威瑞森、蒙特利尔银行等超40家高分红股如何布局！投资者可在除息前布局，赚取股息！一文速览派息名单>>
01-02 20:45
Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026
Drugmakers to raise US prices on 350+ branded medicines in 2026, including COVID vaccines and cancer therapies, despite pressure from Trump.
2025-12-31 21:59
公司简介
公司名称
|
辉瑞
|
行业分类
|
制药
|
业务描述
|
在辉瑞，我们致力于运用科学以及我们的全球资源来改善每个生命阶段的健康状况。在药品的探索、开发和生产过程中，我们多样化的全球保健产品包括生物药品、小分子药品和疫苗，以及许多世界驰名的健康药物。每天，世界各地的辉瑞员工致力于推进健康，以及能够应对我们这个时代最为棘手的疾病的预防和治疗方案。辉瑞还与世界各地的医疗卫生专业人士、政府和社区合作，支持世界各地的人们能够获得更为可靠和可承付的医疗卫生服务。这与辉瑞作为一家世界领先的生物制药公司的责任是一致的。160多年来，辉瑞一直努力为人们提供更好、更优质的服务。
2016年收入528亿美元，全球63个生产基地，业务遍布全球约175个国家和地区，有9种产品的销售额超过10亿美元，2016年新增140多个研发合作机构，全球96,500余名员工。
|
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
25分钟前
美股异动 | 减肥药概念走高 礼来(LLY.US)涨超4%破历史新高
周三，减肥药概念走高，礼来(LLY.US)涨超4%破历史新高，安进(AMGN.US)涨超3%，诺和诺德(NVO.US)、辉瑞(PFE.US)涨超1%。
01-07 23:00
“专利悬崖”大限将至 制药行业或迎来新一轮资产争夺战
①全球多款畅销药面临专利保护到期，预计到2032年将给制药巨头造成至少1739亿美元的年销售额损失； ②为填补收入缺口，制药公司正通过并购、合作、授权等方式获取新药或创新成果，预计2026年并购活动可能进一步升温。
01-07 21:57
UBS Assumes Pfizer at Neutral, Announces Price Target of $25
UBS analyst Michael Yee assumes Pfizer (NYSE:PFE) with a Neutral rating and announces Price Target of $25.
01-07 21:45
8.65亿！辉瑞又出手了
（来源：动脉新医药） 1月6日，辉瑞（Pfizer）宣布与美国肿瘤免疫疗法公司Cartography Biosciences达成一项研发合作，双方将围绕“肿瘤选...
01-07 18:20
拜耳就mRNA技术起诉美国新冠疫苗制造商
拜耳旗下的孟山都公司周二在特拉华州联邦法院起诉新冠疫苗生产商辉瑞、BioNTech和Moderna，指控它们在生产疫苗时滥用其mRNA技术。该专利侵权诉讼称，这...
01-07 04:41
Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development
Outlook Therapeutics, Inc. announced the appointment of Laura Cantrell as Vice President of Corporate Strategy and Business Development. Cantrell, with over 20 years of experience in biotechnology, will lead the company's business development strategies, strategic partnerships, and corporate initiatives. Her expertise will support the company's mission to enhance bevacizumab treatments for retina diseases and maximize shareholder value.
01-06 13:35
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Nurix Therapeutics, Inc. announced that its CEO, Arthur T. Sands, M.D., Ph.D., will present a corporate update at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, in San Francisco. The presentation will be available via webcast on the company's website. Nurix, focused on targeted protein degradation medicines for oncology and autoimmune diseases, has a clinical-stage pipeline including BTK degraders and CBL-B inhibitors, as ...
01-05 12:00
美股1月收息策略：最高股息率超8%！辉瑞、蒙特利尔银行等超40家高分红股如何布局！
最高股息率超8%！辉瑞、丰业银行、威瑞森、蒙特利尔银行等超40家高分红股如何布局！投资者可在除息前布局，赚取股息！一文速览派息名单>>
01-02 20:45
Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026
Drugmakers to raise US prices on 350+ branded medicines in 2026, including COVID vaccines and cancer therapies, despite pressure from Trump.
2025-12-31 21:59
派息除权日
|
每股总股息
| 派息日期 |
2026-01-23
|
0.43
|
2026-03-06
|
2025-11-07
|
0.43
|
2025-12-01
|
2025-07-25
|
0.43
|
2025-09-02
|
2025-05-09
|
0.43
|
2025-06-13
|
2025-01-24
|
0.43
|
2025-03-07
|
2024-11-08
|
0.42
|
2024-12-02
|
2024-07-26
|
0.42
|
2024-09-03
|
2024-05-09
|
0.42
|
2024-06-14
|
2024-01-25
|
0.42
|
2024-03-01
|
2023-11-09
|
0.41
|
2023-12-04
|
2023-07-27
|
0.41
|
2023-09-05
|
2023-05-11
|
0.41
|
2023-06-09
|
2023-01-26
|
0.41
|
2023-03-03
|
2022-11-03
|
0.40
|
2022-12-05
|
2022-07-28
|
0.40
|
2022-09-06
|
2022-05-12
|
0.40
|
2022-06-10
|
2022-01-27
|
0.40
|
2022-03-04
|
2021-11-04
|
0.39
|
2021-12-06
|
2021-07-29
|
0.39
|
2021-09-07
|
2021-05-06
|
0.39
|
2021-06-04
|
2021-01-28
|
0.39
|
2021-03-05
|
2020-11-05
|
0.38
|
2020-12-01
|
2020-07-30
|
0.38
|
2020-09-01
|
2020-05-07
|
0.38
|
2020-06-05
|
2020-01-30
|
0.38
|
2020-03-06
|
2019-11-07
|
0.36
|
2019-12-02
|
2019-08-01
|
0.36
|
2019-09-03
|
2019-05-09
|
0.36
|
2019-06-07
|
2019-01-31
|
0.36
|
2019-03-01
|
2018-11-08
|
0.34
|
2018-12-03
|
2018-08-02
|
0.34
|
2018-09-04
|
2018-05-10
|
0.34
|
2018-06-01
|
2018-02-01
|
0.34
|
2018-03-01
|
2017-11-09
|
0.32
|
2017-12-01
|
2017-08-02
|
0.32
|
2017-09-01
|
2017-05-10
|
0.32
|
2017-06-01
|
2017-02-01
|
0.32
|
2017-03-01
|
2016-11-08
|
0.30
|
2016-12-01
|
2016-08-03
|
0.30
|
2016-09-01
|
2016-05-11
|
0.30
|
2016-06-01
|
2016-02-03
|
0.30
|
2016-03-02
|
2015-11-04
|
0.28
|
2015-12-01
|
2015-08-05
|
0.28
|
2015-09-02
|
2015-05-06
|
0.28
|
2015-06-02
|
2015-02-04
|
0.28
|
2015-03-03
|
2014-11-05
|
0.26
|
2014-12-02
|
2014-07-30
|
0.26
|
2014-09-03
|
2014-05-07
|
0.26
|
2014-06-03
|
2014-02-05
|
0.26
|
2014-03-04
|
2013-11-06
|
0.24
|
2013-12-03
|
2013-07-31
|
0.24
|
2013-09-04
|
2013-05-08
|
0.24
|
2013-06-04
|
2013-01-30
|
0.24
|
2013-03-05
|
2012-11-07
|
0.22
|
2012-12-04
|
2012-08-01
|
0.22
|
2012-09-05
|
2012-05-09
|
0.22
|
2012-06-05
|
2012-02-01
|
0.22
|
2012-03-06
|
2011-11-08
|
0.20
|
2011-12-06
|
2011-08-03
|
0.20
|
2011-09-06
|
2011-05-11
|
0.20
|
2011-06-07
|
2011-02-02
|
0.20
|
2011-03-01
|
2010-11-04
|
0.18
|
2010-12-01
|
2010-08-04
|
0.18
|
2010-09-01
|
2010-05-05
|
0.18
|
2010-06-01
|
2010-02-03
|
0.18
|
2010-03-02
|
2009-11-04
|
0.16
|
2009-12-01
|
2009-08-05
|
0.16
|
2009-09-02
|
2009-05-06
|
0.16
|
2009-06-02
|
2009-02-04
|
0.32
|
2009-03-03
|
2008-11-05
|
0.32
|
2008-12-02
|
2008-08-06
|
0.32
|
2008-09-03
|
2008-05-07
|
0.32
|
2008-06-03
|
2008-02-06
|
0.32
|
2008-03-04
|
2007-11-07
|
0.29
|
2007-12-04
|
2007-08-08
|
0.29
|
2007-09-05
|
2007-05-09
|
0.29
|
2007-06-05
|
2007-02-07
|
0.29
|
2007-03-06
|
2006-11-08
|
0.24
|
2006-12-05
|
2006-08-09
|
0.24
|
2006-09-05
|
2006-05-10
|
0.24
|
2006-06-06
|
2006-02-08
|
0.24
|
2006-03-07
|
2005-11-08
|
0.19
|
2005-12-06
|
2005-08-10
|
0.19
|
2005-09-06
|
2005-05-11
|
0.19
|
2005-06-07
|
2005-02-09
|
0.19
|
2005-03-08
|
2004-11-09
|
0.17
|
2004-12-03
|
2004-08-11
|
0.17
|
2004-09-03
|
2004-05-12
|
0.17
|
2004-06-04
|
2004-02-11
|
0.17
|
2004-03-05
|
2003-11-12
|
0.15
|
2003-12-04
|
2003-08-13
|
0.15
|
2003-09-04
|
2003-05-14
|
0.15
|
2003-06-05
|
2003-01-15
|
0.15
|
2003-02-14
|
2002-11-13
|
0.13
|
2002-12-05
|
2002-08-14
|
0.13
|
2002-09-05
|
2002-05-15
|
0.13
|
2002-06-06
|
2002-02-13
|
0.13
|
2002-03-07
|
2001-11-14
|
0.11
|
2001-12-06
|
2001-08-15
|
0.11
|
2001-09-06
|
2001-05-16
|
0.11
|
2001-06-07
|
2001-02-14
|
0.11
|
2001-03-08
|
2000-11-15
|
0.09
|
2000-12-07
|
2000-08-16
|
0.09
|
2000-09-07
|
2000-05-09
|
0.09
|
2000-06-08
|
2000-02-16
|
0.09
|
2000-03-09
|
1999-11-09
|
0.08
|
1999-12-09
|
1999-08-04
|
0.08
|
1999-09-09
|
1999-05-05
|
0.22
|
1999-06-10
|
1999-02-10
|
0.22
|
1999-03-11
|
1998-11-04
|
0.19
|
1998-12-10
|
1998-08-05
|
0.19
|
1998-09-10
|
1998-05-06
|
0.19
|
1998-06-11
|
1998-02-04
|
0.19
|
1998-03-12
|
1997-11-05
|
0.17
|
1997-12-11
|
1997-07-30
|
0.17
|
1997-09-11
|
1997-05-07
|
0.34
|
1997-06-12
|
1997-02-05
|
0.34
|
1997-03-13
|
1996-11-06
|
0.30
|
1996-12-12
|
1996-07-31
|
0.30
|
1996-09-12
|
1996-05-08
|
0.30
|
1996-06-13
|
1996-02-07
|
0.30
|
1996-03-14
|
1995-11-08
|
0.26
|
1995-12-21
|
1995-08-02
|
0.26
|
1995-09-21
|
1995-05-08
|
0.52
|
1995-06-15
|
1995-02-06
|
0.52
|
1995-03-16
|
1994-11-04
|
0.47
|
1994-12-15
|
1994-08-01
|
0.47
|
1994-09-15
|
1994-05-09
|
0.47
|
1994-06-16
|
1994-02-07
|
0.47
|
1994-03-17
|
1993-11-05
|
0.42
|
1993-12-16
|
1993-08-02
|
0.42
|
1993-09-16
|
1993-05-10
|
0.42
|
1993-06-17
|
1993-02-08
|
0.42
|
1993-03-18
|
1992-11-16
|
0.37
|
1992-12-17
|
1992-08-03
|
0.37
|
1992-09-17
|
1992-05-11
|
0.37
|
1992-06-18
|
1992-02-03
|
0.37
|
1992-03-19
|
1991-11-08
|
0.33
|
1991-12-19
|
1991-08-01
|
0.33
|
1991-09-19
|
1991-05-13
|
0.33
|
1991-06-20
|
1991-02-22
|
0.66
|
1991-03-21
|
1990-11-09
|
0.60
|
1990-12-20
|
1990-08-06
|
0.60
|
1990-09-20
|
1990-05-14
|
0.60
|
1990-06-21
|
1990-02-05
|
0.60
|
1990-03-22
|
1989-11-13
|
0.55
|
1989-12-21
|
1989-07-24
|
0.55
|
1989-09-21
|
1989-05-15
|
0.55
|
1989-06-21
|
1989-01-23
|
0.55
|
1989-03-22
|
1988-11-15
|
0.50
|
1988-12-20
|
1988-07-25
|
0.50
|
1988-09-20
|
1988-05-16
|
0.50
|
1988-06-20
|
1988-02-12
|
0.50
|
1988-03-21
|
1987-11-16
|
0.45
|
1987-12-21
|
1987-07-27
|
0.45
|
1987-09-21
|
1987-05-14
|
0.45
|
1987-06-19
|
1987-01-26
|
0.45
|
1987-03-20
|
1986-11-17
|
0.41
|
1986-12-19
|
1986-07-28
|
0.41
|
1986-09-19
|
1986-05-14
|
0.41
|
1986-06-20
|
1986-01-27
|
0.41
|
1986-03-21
|
1985-11-15
|
0.37
|
1985-12-20
|
1985-07-26
|
0.37
|
1985-09-20
|
1985-05-20
|
0.37
|
1985-06-21
|
1985-01-28
|
0.37
|
1985-03-21
|
1984-11-13
|
0.33
|
1984-12-20
|
1984-07-26
|
0.33
|
1984-09-20
|
1984-05-14
|
0.33
|
1984-06-21
|
1984-01-26
|
0.33
|
1984-03-21
|
1983-11-14
|
0.29
|
1983-12-21
|
1983-07-26
|
0.29
|
1983-09-21
|
1983-05-13
|
0.58
|
1983-06-21
|
1983-01-26
|
0.58
|
1983-03-21
|
1982-11-15
|
0.46
|
1982-12-21
|
1982-07-27
|
0.46
|
1982-09-21
|
1982-05-13
|
0.46
|
1982-06-21
|
1982-01-26
|
0.46
|
1982-03-19
|
1981-11-13
|
0.40
|
1981-12-21
|
1981-08-13
|
0.40
|
1981-09-21
|
1981-05-13
|
0.40
|
1981-06-19
|
1981-02-11
|
0.40
|
1981-03-20
|
1980-11-28
|
0.36
|
1980-12-22
|
1980-09-02
|
0.36
|
1980-09-29
|
1980-05-29
|
0.36
|
1980-06-27
|
1980-03-03
|
0.36
|
1980-03-30
|
1979-11-22
|
0.33
|
1979-12-18
|
1979-08-27
|
0.33
|
1979-09-20
|
1979-05-23
|
0.33
|
1979-06-21
|
1979-03-05
|
0.33
|
1979-03-29
|
1978-11-21
|
0.30
|
1978-12-17
|
1978-08-28
|
0.30
|
1978-09-21
|
1978-05-25
|
0.30
|
1978-06-22
|
1978-02-27
|
0.27
|
1978-03-23
|
1977-11-24
|
0.27
|
1977-12-18
|
1977-09-01
|
0.24
|
1977-09-22
|
1977-05-30
|
0.24
|
1977-06-23
|
1977-02-28
|
0.24
|
1977-03-24
|
